These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24321698)

  • 1. QSAR, docking, dynamic simulation and quantum mechanics studies to explore the recognition properties of cholinesterase binding sites.
    Correa-Basurto J; Bello M; Rosales-Hernández MC; Hernández-Rodríguez M; Nicolás-Vázquez I; Rojo-Domínguez A; Trujillo-Ferrara JG; Miranda R; Flores-Sandoval CA
    Chem Biol Interact; 2014 Feb; 209():1-13. PubMed ID: 24321698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docking and quantum mechanic studies on cholinesterases and their inhibitors.
    Correa-Basurto J; Flores-Sandoval C; Marín-Cruz J; Rojo-Domínguez A; Espinoza-Fonseca LM; Trujillo-Ferrara JG
    Eur J Med Chem; 2007 Jan; 42(1):10-9. PubMed ID: 17055616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations.
    Vitorović-Todorović MD; Koukoulitsa C; Juranić IO; Mandić LM; Drakulić BJ
    Eur J Med Chem; 2014 Jun; 81():158-75. PubMed ID: 24836068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies.
    Korabecny J; Dolezal R; Cabelova P; Horova A; Hruba E; Ricny J; Sedlacek L; Nepovimova E; Spilovska K; Andrs M; Musilek K; Opletalova V; Sepsova V; Ripova D; Kuca K
    Eur J Med Chem; 2014 Jul; 82():426-38. PubMed ID: 24929293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biological evaluation, QSAR study and molecular docking of novel N-(4-amino carbonylpiperazinyl) (thio)phosphoramide derivatives as cholinesterase inhibitors.
    Gholivand K; Ebrahimi Valmoozi AA; Bonsaii M
    Pestic Biochem Physiol; 2014 Jun; 112():40-50. PubMed ID: 24974116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Aryl-4-oxo-N-phenyl-2-aminylbutyramides as acetyl- and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure-activity relationship based on molecular interaction fields.
    Vitorović-Todorović MD; Juranić IO; Mandić LM; Drakulić BJ
    Bioorg Med Chem; 2010 Feb; 18(3):1181-93. PubMed ID: 20061157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors.
    Daoud I; Melkemi N; Salah T; Ghalem S
    Comput Biol Chem; 2018 Jun; 74():304-326. PubMed ID: 29747032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics simulation study and molecular docking descriptors in structure-based QSAR on acetylcholinesterase (AChE) inhibitors.
    Gharaghani S; Khayamian T; Ebrahimi M
    SAR QSAR Environ Res; 2013; 24(9):773-94. PubMed ID: 23863115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
    Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
    Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microwave assisted synthesis, cholinesterase enzymes inhibitory activities and molecular docking studies of new pyridopyrimidine derivatives.
    Basiri A; Murugaiyah V; Osman H; Kumar RS; Kia Y; Ali MA
    Bioorg Med Chem; 2013 Jun; 21(11):3022-31. PubMed ID: 23602518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylcholinesterase inhibitors: structure based design, synthesis, pharmacophore modeling, and virtual screening.
    Valasani KR; Chaney MO; Day VW; Shidu Yan S
    J Chem Inf Model; 2013 Aug; 53(8):2033-46. PubMed ID: 23777291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
    Camps P; Formosa X; Galdeano C; Gómez T; Muñoz-Torrero D; Scarpellini M; Viayna E; Badia A; Clos MV; Camins A; Pallàs M; Bartolini M; Mancini F; Andrisano V; Estelrich J; Lizondo M; Bidon-Chanal A; Luque FJ
    J Med Chem; 2008 Jun; 51(12):3588-98. PubMed ID: 18517184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of new donepezil-hydrazinonicotinamide hybrids.
    Zurek E; Szymański P; Mikiciuk-Olasik E
    Drug Res (Stuttg); 2013 Mar; 63(3):137-44. PubMed ID: 23447117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular docking and 3D-QSAR studies of 2-substituted 1-indanone derivatives as acetylcholinesterase inhibitors.
    Shen LL; Liu GX; Tang Y
    Acta Pharmacol Sin; 2007 Dec; 28(12):2053-63. PubMed ID: 18031622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T; Zhu L; Chen L; Xu X
    J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and crystal structure of new temephos analogues as cholinesterase inhibitor: molecular docking, QSAR study, and hydrogen bonding analysis of solid state.
    Gholivand K; Ebrahimi Valmoozi AA; Bonsaii M
    J Agric Food Chem; 2014 Jun; 62(25):5761-71. PubMed ID: 24893121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ab initio molecular simulations for proposing potent inhibitors to butyrylcholinesterases.
    Murakawa T; Matsushita Y; Suzuki T; Khan MT; Kurita N
    J Mol Graph Model; 2014 Nov; 54():54-61. PubMed ID: 25259414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical and molecular aspects on interactions of galanthamine and its derivatives with cholinesterases.
    Gulcan HO; Orhan IE; Sener B
    Curr Pharm Biotechnol; 2015; 16(3):252-8. PubMed ID: 25483718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.